Bausch + Lomb and Novaliq Announce FDA Approval of MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) for the Treatment of the Signs and Symptoms of Dry Eye Disease

×

错误信息

  • Notice: Undefined property: stdClass::$ds_changed 在 eval() (行 16/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ss_search_api_url 在 eval() (行 20/var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$tm_title 在 eval() (行 20/var/www/7/modules/php/php.module(80) : eval()'d code).

MIEBO is the first and only FDA-approved treatment for DED that directly targets tear evaporation.